See more : Royal Orchid Hotels Limited (ROHLTD.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Anzu Special Acquisition Corp I (ANZUU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Anzu Special Acquisition Corp I, a leading company in the Shell Companies industry within the Financial Services sector.
- Tianjin Guangyu Development Co., Ltd. (000537.SZ) Income Statement Analysis – Financial Results
- Zengame Technology Holding Limited (2660.HK) Income Statement Analysis – Financial Results
- Power Metals Corp. (PWRMF) Income Statement Analysis – Financial Results
- Southport Acquisition Corporation (PORT-UN) Income Statement Analysis – Financial Results
- Poulaillon SA (ALPOU.PA) Income Statement Analysis – Financial Results
Anzu Special Acquisition Corp I (ANZUU)
About Anzu Special Acquisition Corp I
Anzu Special Acquisition Corp I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of industrial applications. The company was incorporated in 2020 and is based in Tampa, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 316.00K | 237.00K | 310.00K | 0.00 |
| Cost of Revenue | 789.00K | 957.00K | 769.00K | 0.00 |
| Gross Profit | -473.00K | -720.00K | -459.00K | 0.00 |
| Gross Profit Ratio | -149.68% | -303.80% | -148.06% | 0.00% |
| Research & Development | 8.96M | 4.52M | 3.94M | 0.00 |
| General & Administrative | 7.28M | 3.47M | 2.47M | 0.00 |
| Selling & Marketing | 1.67M | 885.00K | 0.00 | 0.00 |
| SG&A | 8.94M | 3.47M | 2.47M | 701.00 |
| Other Expenses | 0.00 | -7.22M | -1.80M | 0.00 |
| Operating Expenses | 17.90M | 7.99M | 6.41M | 701.00 |
| Cost & Expenses | 18.69M | 8.94M | 7.18M | 701.00 |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 133.00K | 75.00K | 71.00K | 206.30K |
| EBITDA | -18.24M | -8.63M | -6.80M | -700.00 |
| EBITDA Ratio | -5,771.52% | -3,641.77% | -2,193.55% | 0.00% |
| Operating Income | -18.37M | -8.71M | -6.87M | -700.00 |
| Operating Income Ratio | -5,813.61% | -3,673.42% | -2,216.45% | 0.00% |
| Total Other Income/Expenses | -11.54M | -7.22M | -1.80M | -1.00 |
| Income Before Tax | -29.91M | -15.92M | -8.68M | -701.00 |
| Income Before Tax Ratio | -9,464.56% | -6,718.57% | -2,798.39% | 0.00% |
| Income Tax Expense | 0.00 | -153.49K | -165.56K | -206.30K |
| Net Income | -29.91M | -15.92M | -8.68M | -701.00 |
| Net Income Ratio | -9,464.56% | -6,718.57% | -2,798.39% | 0.00% |
| EPS | -2.38 | -1.57 | -0.85 | 0.00 |
| EPS Diluted | -2.38 | -1.57 | -0.85 | 0.00 |
| Weighted Avg Shares Out | 12.55M | 10.15M | 10.15M | 60.38M |
| Weighted Avg Shares Out (Dil) | 12.55M | 10.15M | 10.15M | 60.38M |
Envoy Medical Corporation and Anzu Special Acquisition Corp I Complete Business Combination
Envoy Medical Announces Shareholder Approval on Proposed Merger with Anzu Special Acquisition Corp I
Envoy Medical Announces Proposed Board Slate of Experienced Medical Device and Financial Leaders
Envoy Medical Appoints David R. Wells as Chief Financial Officer
CORRECTING and REPLACING Anzu Special Acquisition Corp I Announces the Separate Trading of Its Class A Common Stock and Warrants, Commencing April 22, 2021
Source: https://incomestatements.info
Category: Stock Reports